Pacific Biosciences of California, Inc. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value
Pacific Biosciences of California, Inc. (PACB) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value of $113.09 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling Maturity, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $113.09M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $136.53M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $153.65M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value $181.71M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value |
|---|---|
| 2026-06-30 | $113.09M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $136.53M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $153.65M 10-K · filed 2026-02-25 |
| 2025-09-30 | $181.71M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $214.59M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $227.68M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $238.96M 10-K · filed 2025-03-17 |
| 2024-09-30 | $321.79M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $347.53M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $380.42M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $498.37M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $652.57M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $634.19M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |